NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Motilal Oswal Reiterates Buy Rating on Cyient DLM

Cyient DLM's (CYIENTDL) consolidated revenue and EBITDA for the fourth quarter of fiscal year 2026 (4QFY26) declined by approximately 14% and 25% year-over-year (YoY) to INR3.7 billion and INR431 million, respectively. This decline was primarily attributed to a higher base of BEL orders and geopolitical disruptions in West Asia. Additionally, the company's EBITDA margins contracted by 170 basis points (bp) YoY due to operating deleverage.

Key Financial Highlights

QuarterRevenue (INR billion)EBITDA (INR million)
4QFY263.7431
4QFY254.3575

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Despite the decline in revenue and EBITDA, Cyient DLM's order book increased by 27% YoY and 3% quarter-over-quarter (QoQ) to INR24.2 billion, driven by an order intake of approximately INR4.4 billion. The company's book-to-bill ratio stood at approximately 1.9x in fiscal year 2026.

Looking ahead, Cyient DLM expects fiscal year 2027 (FY27) to be better than FY26, led by new client additions, improving order book, and high-margin orders. These factors are expected to help the company sustain 4Q-level margins in FY27.

Outlook and Recommendation

For CYIENTDL, Motilal Oswal estimates a compound annual growth rate (CAGR) of 24%, 36%, and 61% in revenue, EBITDA, and adjusted profit after tax (PAT) over FY26-28. Based on this outlook, the research firm reiterates its buy rating on the stock with a target price of INR470 (25x FY28E EPS).

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Investor Takeaway

Investors should consider buying Cyient DLM stock with a target price of Rs 470.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.